{"id":"2-hydroxyflutamide","safety":{"commonSideEffects":[{"rate":"10%","effect":"Gynecomastia"},{"rate":"20%","effect":"Hot flashes"},{"rate":"30%","effect":"Impotence"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"2-Hydroxyflutamide acts as a non-steroidal anti-androgen that competitively inhibits the action of androgens, such as testosterone and dihydrotestosterone, at the androgen receptor.","oneSentence":"Anti-androgen receptor antagonist","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T06:32:02.261Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prostate cancer"}]},"trialDetails":[{"nctId":"NCT03348527","phase":"PHASE2","title":"A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer","status":"COMPLETED","sponsor":"Lidds AB","startDate":"2017-05-12","conditions":"Prostate Cancer","enrollment":61},{"nctId":"NCT02341404","phase":"PHASE2","title":"A Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate Cancer","status":"COMPLETED","sponsor":"Lidds AB","startDate":"2012-05","conditions":"Prostate Cancer","enrollment":23},{"nctId":"NCT00913263","phase":"PHASE1, PHASE2","title":"An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the Prostate","status":"COMPLETED","sponsor":"Lidds AB","startDate":"2009-06","conditions":"Prostate Cancer","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Liproca Depot"],"phase":"phase_1","status":"active","brandName":"2-Hydroxyflutamide","genericName":"2-Hydroxyflutamide","companyName":"Lidds AB","companyId":"lidds-ab","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Anti-androgen receptor antagonist Used for Prostate cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}